This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yufeng Chen: Innovator in Cancer Treatment
Introduction
Yufeng Chen is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical biological pathways involved in various diseases.
Latest Patents
Yufeng Chen holds a patent for a high-activity Wnt pathway inhibitor compound. This compound is designed to inhibit Wnt pathway activity and is included in a pharmaceutical composition aimed at preventing and treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases. His innovative work in this area has the potential to impact many lives.
Career Highlights
Chen is associated with Adlai Nortye Biopharma Co., Ltd., where he continues to advance his research and development efforts. His expertise in the pharmaceutical industry has positioned him as a key player in the fight against serious health conditions.
Collaborations
Yufeng Chen collaborates with talented individuals such as Peng Wu and Meng Lv, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yufeng Chen's work exemplifies the vital role of inventors in the advancement of medical science. His contributions to the development of Wnt pathway inhibitors highlight the importance of innovation in addressing complex health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile